Market Research Logo

OTC Pharmaceuticals in Asia-Pacific

OTC Pharmaceuticals in Asia-Pacific

Summary

OTC Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings

  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Asia-Pacific
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Asia-Pacific
  • Leading company profiles reveal details of key otc pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific otc pharmaceuticals market with five year forecasts
Synopsis

Essential resource for top-line data and analysis covering the Asia-Pacific otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons To Buy
  • What was the size of the Asia-Pacific otc pharmaceuticals market by value in 2015?
  • What will be the size of the Asia-Pacific otc pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the Asia-Pacific otc pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in Asia-Pacific's otc pharmaceuticals market?
Key Highlights

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2015 annual average exchange rates.

The Asia-Pacific OTC pharmaceuticals market generated total revenues of $45,821.5m in 2015, representing a compound annual growth rate (CAGR) of 0.2% between 2011 and 2015.

Traditional medicines recorded the highest sales value in the Asia-Pacific OTC pharmaceuticals market in 2015, with total sales of $17,084.2m, equivalent to 37.3% of the market's overall value.

China's large ageing population and inequity in healthcare provision may be behind the strong growth.


Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market share
Market distribution
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
GlaxoSmithKline Plc
Johnson & Johnson
Nin Jiom Medicines Manufactory Ltd
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: Asia-Pacific OTC pharmaceuticals market value: $ million, 2011–15
Table 2: Asia–Pacific OTC pharmaceuticals market category segmentation: $ million, 2015
Table 3: Asia–Pacific OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 4: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2015
Table 5: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2015
Table 6: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 2015–20
Table 7: Bayer AG: key facts
Table 8: Bayer AG: key financials ($)
Table 9: Bayer AG: key financials (€)
Table 10: Bayer AG: key financial ratios
Table 11: GlaxoSmithKline Plc: key facts
Table 12: GlaxoSmithKline Plc: key financials ($)
Table 13: GlaxoSmithKline Plc: key financials (£)
Table 14: GlaxoSmithKline Plc: key financial ratios
Table 15: Johnson & Johnson: key facts
Table 16: Johnson & Johnson: key financials ($)
Table 17: Johnson & Johnson: key financial ratios
Table 18: Nin Jiom Medicines Manufactory Ltd: key facts
List of Figures
Figure 1: Asia-Pacific OTC pharmaceuticals market value: $ million, 2011–15
Figure 2: Asia–Pacific OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 3: Asia–Pacific OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 4: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2015
Figure 5: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 6: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 2015–20
Figure 7: Forces driving competition in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 13: Bayer AG: revenues & profitability
Figure 14: Bayer AG: assets & liabilities
Figure 15: GlaxoSmithKline Plc: revenues & profitability
Figure 16: GlaxoSmithKline Plc: assets & liabilities
Figure 17: Johnson & Johnson: revenues & profitability
Figure 18: Johnson & Johnson: assets & liabilities

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report